Norwood, MA Newmark has completed the $105 million sale of One Investors Way, a biomanufacturing campus redevelopment opportunity. Newmark co-head of U.S. Capital Markets Robert Griffin, vice chairman Edward Maher, executive managing director Matthew Pullen and managing director Samantha Hallowell of the firm’s Boston Capital Markets Group represented the seller, U.S. Realty Advisors and Bain Capital Real Estate, and procured the buyer. Senior financial analyst Will Sleeper provided financial analysis support.
Set on a 54-acre site, One Investors Way includes an existing 236,566 s/f office building that is primed for repositioning coupled with excess land that is well positioned for new construction.
“One Investors Way presents an exceptional opportunity to capitalize on the Greater Boston market’s insatiable demand for biomanufacturing inventory,” said Matthew. “The property benefits from prime positioning just 20 miles from Cambridge along suburban Boston’s coveted Rte. 128/I-95 corridor.”
One Investors Way is surrounded by a biomanufacturing-anchored campus that serves as home to a two-building flagship for biotechnology company Moderna and a 260-unit apartment community. Nearby amenities include University Station in Westwood and Legacy Place in Dedham.